PBMT on Muscular Performance and Recovery in Different Time-points

NCT ID: NCT03420391

Last Updated: 2020-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-20

Study Completion Date

2019-07-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recent studies with photobiomodulation therapy (PBMT) have shown positive results delaying skeletal muscle fatigue and improving the status of biochemical markers related to skeletal muscle damage when these therapies were applied before exercise. The aim of this project is to verify the effects of PBMT in improvement of skeletal muscle performance and skeletal muscle recovery in healthy male subjects. This project aim also to validate the concept that simultaneous use of three wavelengths and light sources lead to optimized action independently of time-window between irradiation and the exercise.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized, triple-blinded, placebo-controlled trial. Sixty healthy untrained male subjects will be randomly allocated to six experimental groups: Placebo, Control, PBMT 5 mins, PBMT 3h, PBMT 6h and PBMT 24 hours. PBMT will be applied precisely two minutes after baseline MVC test. Then, after five minutes, 3, 6 hours or 1 day (24 hours) of PBMT the eccentric exercise protocol will be performed. We will analyze maximum voluntary contraction (MVC), creatine kinase (CK) activity and delayed onset muscle soreness (DOMS). Assessments will be performed at baseline, immediately after (1 minute), 1 hour, 24 and 48 hours after the eccentric exercise protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phototherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Sixty participants will be enrolled in the study. Participants will be randomized in six groups:

Control: Participants will receive no intervention; Placebo: Participants will receive placebo PBMT; 5 minutes: Participants will perform the eccentric exercise protocol 5 minutes after PBMT.

3 hours: Participants will perform the eccentric exercise protocol 3 hours after PBMT.

6 hours: Participants will perform the eccentric exercise protocol 6 hours after PBMT.

24 hours: Participants will perform the eccentric exercise protocol 24 hours after PBMT.

Assessments will be performed at baseline, after 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo PBMT

Participants will be treated with placebo PBMT in different time-points before the eccentric exercise protocol (5 minutes, 3 hours, 6 hours or 24 hours). Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.

Group Type PLACEBO_COMPARATOR

Photobiomodulation Therapy (PBMT)

Intervention Type DEVICE

Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)

5 Minutes

Participants will be performed the eccentric exercise protocol 5 minutes after PBMT.

Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.

Group Type ACTIVE_COMPARATOR

Photobiomodulation Therapy (PBMT)

Intervention Type DEVICE

Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)

3 Hours

3 hours: Participants will be performed the eccentric exercise protocol 3 hours after PBMT.

Assessments will be performed before at baseline, 1 minute, 1 hour and 24, 48 hours after the end of exercise protocol.

Group Type ACTIVE_COMPARATOR

Photobiomodulation Therapy (PBMT)

Intervention Type DEVICE

Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)

6 Hours

6 hours: Participants will be performed the eccentric exercise protocol 6 hours after PBMT.

Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.

Group Type ACTIVE_COMPARATOR

Photobiomodulation Therapy (PBMT)

Intervention Type DEVICE

Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)

24 hours

24 hours: Participants will be performed the eccentric exercise protocol 24 hours after PBMT. Assessments will be performed before at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.

Group Type ACTIVE_COMPARATOR

Photobiomodulation Therapy (PBMT)

Intervention Type DEVICE

Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)

Control

Participants will not receive intervention. Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Photobiomodulation Therapy (PBMT)

Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* not athletes or who engage in physical activity at most once a week
* Individuals should not present a history of musculoskeletal injury in the hip and knee regions in the two months prior to the studies
* they should not be using pharmacological agents and / or nutritional supplements
* They must attend 100% of the data collections.

Exclusion Criteria

* Individuals who do not meet the criteria mentioned above or who present musculoskeletal damage during collection were excluded from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

Sponsor Role collaborator

University of Bergen

OTHER

Sponsor Role collaborator

University of Nove de Julho

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ernesto Cesar Pinto Leal Junior

Full professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidade Nove de Julho

São Paulo, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Leal-Junior ECP, de Oliveira MFD, Joensen J, Stausholm MB, Bjordal JM, Tomazoni SS. What is the optimal time-response window for the use of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) for the improvement of exercise performance and recovery, and for how long the effects last? A randomized, triple-blinded, placebo-controlled trial. BMC Sports Sci Med Rehabil. 2020 Oct 19;12:64. doi: 10.1186/s13102-020-00214-8. eCollection 2020.

Reference Type DERIVED
PMID: 33088573 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

113553

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.